Concepedia

Author

Hédia Brixi

Université de Reims Champagne-ArdenneORCID

Also Known As

Brixi, Hedia, Florence Harnois, H Brixi, H. Brixi, Hedia Brixi, Hédia Brixi, Karine Amouriaux

71

Publications

2.8K

Citations

25

H-Index

43

Concepts

All Affiliations

Université de Reims Champagne-ArdenneHôpital BeaujonInsermUniversité Paris CitéHôpital Robert-Debré
HB

About

Hédia Brixi is an author at Université de Reims Champagne-Ardenne specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

1.3K

2

Gastroenterology

14

14

1.3K

3

Public Health

2

2

382

4

Epidemiology

2

2

382

5

Hepatology

1

1

19

Hédia Brixi

×

31

Publications

2.3K

Citations

22

H-Index

YearCitations

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

Laurent Beaugerie, Magali Svrcek, Philippe Seksik,

Gastroenterology

2013

353

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Yoram Bouhnik, Franck Carbonnel, David Laharie,

Gut

2017

315

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Geert D’Haens, Séverine Vermeire, Guy Lambrecht,

Gastroenterology

2018

295

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents

Pauline Wils, Yoram Bouhnik, Pierre Michetti,

Clinical Gastroenterology and Hepatology

2015

169

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Driffa Moussata, Matthieu Allez, Dominique Cazals‐Hatem,

Gut

2017

163

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

Franck Carbonnel, Jean‐Frédéric Colombel, Jérôme Filippi,

Gastroenterology

2015

138

Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

Pauline Wils, Yoram Bouhnik, Pierre Michetti,

Alimentary Pharmacology & Therapeutics

2018

100

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis

Gauthier Pellet, Carmen Stefănescu, Franck Carbonnel,

Clinical Gastroenterology and Hepatology

2018

79

Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery

Sophie Lardière-Deguelte, Louis de Mestier, F. Appere,

Neuroendocrinology

2015

76

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

Pauline Wils, Philippe Seksik, Carmen Stefănescu,

Alimentary Pharmacology & Therapeutics

2020

73

Page 1